BM, BCH, MA, MRCGP, DPhil
Professor of Evidence-Based Medicine
- Director of CEBM & Programs in EBHC
- Editor in Chief, BMJ EBM
- NHS Urgent Care GP and NIHR Senior Investigator
Carl Heneghan is an epidemiologist and has expertise in EBM, research methods and the regulation of drugs and devices.
He has considerable experience in NonCommunicable Diseases having published widely on the topic and is Director of a World Health Organization Collaboration Centre
His work includes investigating drug and devices, advising governments on regulatory evidence and working extensively with the public and the media to communicate research findings.
He has investigated the evidence for sports drinks, IVF 'Add-on' treatments, metal-hips, screening, surgical mesh, medical devices and hormone pregnancy tests. In 2019 he received a lifetime achievement award from Oxford's Medical Science Division for his sustained commitment to education and teaching.
He teaches undergraduates, postgraduates and teachers of EBM, and is the Director of Programs in Evidence-Based Health Care, and supervises DPhil projects based in Kenya, Egypt, North America and the UK
He is a clinical advisor to the UK's Parliaments All Parliamentary Party Group on Surgical Mesh and Hormone Pregnancy Tests, and A founder of the AllTrials campaign twice voted one of the top 100 NHS clinical leaders by the HSJ. In 2018 he was awarded NIHR Senior Investigator status
- Over 400 peer-reviewed publications (current H Index 62) and co-authored the EBM toolkit and Statistics Toolkit (BMJ-Blackwell’s) and, developed the EvidenceLive conference, now in its 10th year.
- Expertise in conducting systematic reviews having Published 91 SRs, and authored the Tamiflu systematic reviews.
- Extensive experience in both print and broadcast media. He is a regular contributor to BBC Radio 4's Inside Health series, the BMJ Talk Evidence Podcast and regularly podcasts his talks on iTunes to download
- An active Twitter account @carlheneghan, Blogs at CEBM and does a regular monthly BM podcast 'Talk Evidence'
Conflicts of interest and payments:
Carl has received expenses and fees for his media work (including payments from BBC Radio 4 Inside Health). He has received expenses from the WHO, FDA, and holds grant funding from the NIHR, the NIHR School of Primary Care Research, The NIHR BRC Oxford and the WHO. He has received financial remuneration from an asbestos case and to date has given legal advice on mesh cases. He has also received income from the publication of a series of toolkit books published by Blackwells. On occasion, he receives expenses for teaching EBM and is also paid for his GP work in NHS out of hours (contract with Oxford Health NHS Foundation Trust). He is Director of CEBM, which jointly runs the EvidenceLive Conference with the BMJ and the Overdiagnosis Conference with international partners, based on a non-profit making model. He is Editor in Chief of BMJ Evidence-Based Medicine and is an NIHR Senior Investigator.
Brodersen J. et al, (2018), BMJ evidence-based medicine, 23, 1 - 3
Nunan D. et al, (2017), BMJ Evidence-based medicine
Hayward GN. et al, (2017), Journal of the American Medical Association
Mahtani KR. et al, (2019), BMJ Evidence-Based Medicine
Heneghan C. and McCartney M., (2019), BMJ, 367
Ferner RE. et al, (2019), BMJ, 367